Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-009841

Options or other derivatives

  • President and CEO acquired 215,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
AHMED NADIM President and CEO 2022-03-05 Grant or award · Performance Stock Unit +215,000 215,000 D
Loading xslF345X03/doc4.xml…